AMN vs. VERA, NARI, KYMR, RCKT, DYN, AGL, CNMD, TGTX, CLDX, and GH
Should you be buying AMN Healthcare Services stock or one of its competitors? The main competitors of AMN Healthcare Services include Vera Therapeutics (VERA), Inari Medical (NARI), Kymera Therapeutics (KYMR), Rocket Pharmaceuticals (RCKT), Dyne Therapeutics (DYN), agilon health (AGL), CONMED (CNMD), TG Therapeutics (TGTX), Celldex Therapeutics (CLDX), and Guardant Health (GH). These companies are all part of the "medical" sector.
AMN Healthcare Services (NYSE:AMN) and Vera Therapeutics (NASDAQ:VERA) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, community ranking, profitability and risk.
AMN Healthcare Services received 413 more outperform votes than Vera Therapeutics when rated by MarketBeat users. Likewise, 69.21% of users gave AMN Healthcare Services an outperform vote while only 53.49% of users gave Vera Therapeutics an outperform vote.
AMN Healthcare Services has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500. Comparatively, Vera Therapeutics has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500.
99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 99.2% of Vera Therapeutics shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 21.7% of Vera Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
AMN Healthcare Services has a net margin of 5.56% compared to Vera Therapeutics' net margin of 0.00%. AMN Healthcare Services' return on equity of 38.29% beat Vera Therapeutics' return on equity.
AMN Healthcare Services has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.
AMN Healthcare Services currently has a consensus price target of $85.00, suggesting a potential upside of 46.86%. Vera Therapeutics has a consensus price target of $32.29, suggesting a potential downside of 22.11%. Given AMN Healthcare Services' higher possible upside, equities analysts clearly believe AMN Healthcare Services is more favorable than Vera Therapeutics.
In the previous week, AMN Healthcare Services had 9 more articles in the media than Vera Therapeutics. MarketBeat recorded 9 mentions for AMN Healthcare Services and 0 mentions for Vera Therapeutics. AMN Healthcare Services' average media sentiment score of 0.15 beat Vera Therapeutics' score of 0.00 indicating that AMN Healthcare Services is being referred to more favorably in the media.
Summary
AMN Healthcare Services beats Vera Therapeutics on 13 of the 18 factors compared between the two stocks.
Get AMN Healthcare Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AMN Healthcare Services Competitors List
Related Companies and Tools
